Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.24.75 extracted from

  • Oluola, O.; Kong, L.; Fein, M.; Weisman, L.E.
    Lysostaphin in treatment of neonatal Staphylococcus aureus infection (2007), Antimicrob. Agents Chemother., 51, 2198-2200.
    View publication on PubMedView publication on EuropePMC
Search for more literature for 3.4.24.75

Application

Application Comment Organism
medicine lysostaphin is useful in treatment of neonatal Staphylococcus aureus infection, overview Staphylococcus simulans

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
additional information Staphylococcus simulans lysostaphin is active in treatment of neonatal Staphylococcus aureus infection by a clinical methicillin-sensitive Staphylococcus aureus serotype 5 strain, overview ?
-
 ?

Organism

Organism UniProt Comment Textmining
Staphylococcus simulans
-
-
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
additional information lysostaphin is active in treatment of neonatal Staphylococcus aureus infection by a clinical methicillin-sensitive Staphylococcus aureus serotype 5 strain, overview Staphylococcus simulans ?
-
 ?